While the positive news about Moderna’s coronavirus vaccine trials is understandably exciting, the story behind their success offers organizations in every sector a dramatic opportunity to take a giant leap forward in their own industries. Among the key players quietly helping Moderna drive efficiencies at a previously unthinkable scale are Harvard Business School Professors and…
How and why are some industry newcomers able to displace well-established giants in record time? According to Karim Lakhani, Harvard Business School professor and expert on AI-driven operating models, the answer lies in digital transformation. His latest case study, which documented the development of Moderna’s COVID-19 vaccine, offers dramatic proof that an AI-centered model offers organizations a powerful…
New vaccines and a new White House administration are promising to finally lift us out of the crushing effects of the pandemic. Some people, however, are still questioning the safety and efficacy of vaccines that were developed so quickly. To dispel myths and set the record straight, these five renowned thought leaders explain what factors…
